Results of the latter study presented recently at the 11th Workshop on Mucins in Health and Disease on sera taken from healthy women who subsequently developed breast cancer did not give any support for the assumption that abs to MUC1 glycopeptides may be used as diagnostic markers [85]. This evidence concerns the gene MUC1 and breast cancer.